Predictors of Stent Restenosis in Han and Uygur Patients with Coronary Heart Disease after PCI in the Xinjiang Region

Table 1

Comparison of clinical data between Han and Uygur ISR and non-ISR patients (, n (%), M (P25, P75).

Characteristic	Han ISR group	Han non-ISR group	χ^2/t		Uygur ISR group	Uygur non-ISR group	χ^2/t
	n = 92	n = 253			n = 30	n = 97
Sex (male n (%)/female n (%))	66 (71.74)/26 (28.26)	188 (74.31)/65 (25.69)	0.229	0.632	26 (86.67)/4 (13.33)	75 (77.32)/22 (22.68)	1.23	0.268
Age (years)	63.1 ± 11.24	60.45 ± 10.63	1.966	0.051	61.03 ± 7.55	58.65 ± 9.73	1.406	0.165
BMI (kg/m^2)	25.48 ± 3.37	25.76 ± 2.79	0.729	0.467	29.66 ± 3.33	28.34 ± 3.76	1.843	0.071
History of hypertension (n (%))	68 (73.91)	157 (62.06)	4.182	0.041	21 (70)	61 (62.89)	0.507	0.477
History of diabetes (n (%))	56 (60.87)	78 (30.83)	25.629	＜0.001	17 (56.67)	25 (25.77)	9.88	0.002
History of myocardial infarction (n (%))	19 (20.65)	61 (24.11)	0.453	0.501	4 (13.33)	10 (10.31)	0.214	0.644
Smoking history (n (%))	42 (45.65)	119 (47.04)	0.052	0.82	16 (53.33)	49 (50.52)	0.073	0.787
Take double antibodies regularly (n (%))	70 (76.09)	199 (78.66)	0.259	0.611	26 (86.67)	83 (85.57)	0.023	0.88
Take statins regularly [n (%)]	76 (82.61)	216 (85.38)	0.397	0.529	26 (86.67)	85 (87.63)	0.019	0.89
Uric acid	349.98 (297.75, 391.2)	339.01 (277.71, 394.86)	1.558	0.212	340.01 (290.68, 409.99)	342 (297.53, 400.23)	0.003	0.961
Serum creatinine	75.89 (63.66, 86.34)	74.14 (62.71, 85.5)	0.716	0.398	78.79 (66.02, 91.64)	76.61 (66.7, 86.88)	0.174	0.677
AST	24.47 (19.55, 31.6)	24.2 (18.9, 29.4)	0.001	0.974	21.57 (16.3, 26.31)	22.3 (17.54, 26.35)	0.613	0.434
ALT	23.91 (17.47, 34.03)	25.58 (16.8, 33.42)	0.884	0.347	20.25 (15.93, 32.72)	25.2 (18.56, 33.43)	0.613	0.434
Triglycerides	1.42 (0.98, 2.14)	1.38 (0.97, 2.02)	0.06	0.807	2.16 (1.2, 2.78)	1.5 (1.04, 2.17)	2.937	0.087
Total cholesterol	3.49 (2.91, 3.91)	3.02 (2.52, 3.48)	9.49	0.002	3.59 (2.99, 4.3)	3.11 (2.67, 3.79)	2.937	0.087
HDL-C	0.92 (0.78, 1.1)	0.96 (0.8, 1.1)	0.017	0.896	0.85 (0.75, 1.05)	0.86 (0.74, 1.07)	0.138	0.71
LDL-C	2.28 (1.76, 2.76)	1.71 (1.35, 2.16)	26.403	＜0.001	1.96 (1.52, 2.91)	1.84 (1.45, 2.34)	0.217	0.642
ApoAI	0.88 (0.67, 1.02)	1.08 (0.96, 1.21)	41.702	＜0.001	0.98 (0.93, 1.14)	0.98 (0.9, 1.11)	0.008	0.928
ApoB	0.78 (0.7, 0.85)	0.71 (0.59, 0.85)	0.443	0.506	1.03 (0.76, 1.24)	0.79 (0.62, 0.97)	5.045	0.025
MCV	92.35 (89.4, 95.6)	92.5 (89.35, 94.9)	0.15	0.698	89.2 (87.75, 91.58)	90.8 (88.1, 93.35)	4.194	0.041
MCH	29 (28.1, 30.7)	30.8 (29.7, 32)	28.767	＜0.001	29.95 (28.7, 30.43)	30 (28.85, 31.1)	0.071	0.79
MCHC	336 (330.25, 344.75)	337 (329, 345)	1.007	0.316	334 (328.75, 343.25)	335 (327, 343)	0.627	0.429
RDW	13 (12.43, 13.4)	12.8 (12.3, 13.3)	3.09	0.079	13.2 (12.7, 13.7)	13.2 (12.55, 13.75)	0.123	0.726
HbA1c	7.25 (6.3, 8.1)	6.2 (5.8, 6.9)	26.259	＜0.001	6.63 (6, 7.93)	6.3 (5.85, 6.9)	1.78	0.182